| Boehringer Ingelheim (Schweiz) GmbH - Viramune, Retardtabletten |
| 62077 | | 01 | | Viramune | | Retardtabletten | | J05AG01 | | Nevirapine | | 10.01.2012 | | |
|
| Composition |
| nevirapinum 400 mg, lactosum monohydricum 400 mg, hypromellosum, magnesii stearas, E 172 (flavum) pro compresso. |
| Packungsbestandteile |
| Delayed release tablets | | | | | Active Agent | Dose |
|---|
| Nevirapine | 400 mg |
| | BAG: Active Agent | Dose |
|---|
| Nevirapine | 400 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) pro Compresso | | | | E 172 | | color. | | Hypromellosum | | | | Lactose Monohydrate | 400 mg | | | Magnesii Stearas | | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 30 Tablet(s) | 180.75 | 211.90 | A | SL | No |
|
